Acute central nervous system graft-versus-host-disease after liver transplantation.


Journal

Transplant immunology
ISSN: 1878-5492
Titre abrégé: Transpl Immunol
Pays: Netherlands
ID NLM: 9309923

Informations de publication

Date de publication:
02 2022
Historique:
received: 26 08 2021
revised: 16 12 2021
accepted: 17 12 2021
pubmed: 25 12 2021
medline: 15 3 2022
entrez: 24 12 2021
Statut: ppublish

Résumé

Acute Central Nervous System (CNS) Graft Versus Host Disease (GvHD) is a rare form of GvHD, only described in case reports. Knowledge about this condition is extrapolated from chronic CNS GvHD cases occurring mostly after hematopoietic stem cell transplantation. GvHD following solid organ transplantation is an unexpected complication. GvHD after liver transplantation has a poor prognosis, and the optimal management is not yet known. Here we describe the case of a 63-year-old man who underwent deceased donor liver transplantation and subsequently developed skin rash, colitis and pancytopenia followed by refractory status epilepticus. Following the identification of lymphocytes of donor origin in the cerebrospinal fluid of the patient, he was diagnosed with acute CNS GvHD. He was treated with an intensive immunosuppressive regimen, but care was withdrawn due to lack of improvement and worsening neurologic prognosis. It is the second known case of acute CNS GvHD following liver transplantation. Clinicians should be aware of this possible, although rare, complication of liver transplantation, especially when there is refractory status epilepticus of unknown origin.

Identifiants

pubmed: 34952167
pii: S0966-3274(21)00161-1
doi: 10.1016/j.trim.2021.101521
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101521

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Valérie Massey (V)

Department of Allergy and Clinical Immunology, Université de Montréal, Montreal, Canada; Centre hospitalier de l'Université de Montréal, Montreal, Canada.

Véronique Martel (V)

Department of Neurosciences, Université de Montréal, Montreal, Canada; Centre hospitalier de l'Université de Montréal, Montreal, Canada.

Dang Khoa Nguyen (DK)

Department of Neurosciences, Université de Montréal, Montreal, Canada; Centre hospitalier de l'Université de Montréal, Montreal, Canada.

Lambert Busque (L)

Department of Hematology, Maisonneuve Rosemont Hospital, Montreal, Canada.

Hugo Chapdelaine (H)

Department of Allergy and Clinical Immunology, Université de Montréal, Montreal, Canada; Centre hospitalier de l'Université de Montréal, Montreal, Canada; Montreal Clinical Research Institute, Canada.

Mark Robert Keezer (MR)

Department of Neurosciences, Université de Montréal, Montreal, Canada; Centre hospitalier de l'Université de Montréal, Montreal, Canada; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada. Electronic address: mark.keezer@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH